Literature DB >> 21110239

Mesenchymal stem cells and innate tolerance: biology and clinical applications.

Cristina Trento1, Francesco Dazzi.   

Abstract

The properties of mesenchymal stem cells (MSC) have been widely investigated during the last decade, from their differentiation capacity to their immunosuppressive effect on any type of immune cell. These properties have been successfully harnessed for the treatment of inflammatory diseases such as graft versus host disease (GvHD). Different mechanisms have been proposed for their immunosuppressive properties, although it seems likely that they are used in concert. The inflammatory environment to which MSC are exposed plays a pivotal role in activating their functions. Conversely, the interplay of MSC with the immunoregulatory networks recruited during inflammation is fundamental to the delivery of immunosuppression. Since other types of terminally differentiated stromal cells share these properties, it is plausible that stemness is not a required feature. Therefore these functions may be involved in the physiological control of acute inflammation in various tissues. These notions highlight the importance of investigating the role of stromal cells as modulators of immune responses.

Entities:  

Mesh:

Year:  2010        PMID: 21110239     DOI: 10.4414/smw.2010.13121

Source DB:  PubMed          Journal:  Swiss Med Wkly        ISSN: 0036-7672            Impact factor:   2.193


  11 in total

1.  Long-term engraftment of multipotent mesenchymal stromal cells that differentiate to form myogenic cells in dogs with Duchenne muscular dystrophy.

Authors:  Yuko Nitahara-Kasahara; Hiromi Hayashita-Kinoh; Sachiko Ohshima-Hosoyama; Hironori Okada; Michiko Wada-Maeda; Akinori Nakamura; Takashi Okada; Shin'ichi Takeda
Journal:  Mol Ther       Date:  2011-09-20       Impact factor: 11.454

2.  In vivo implanted bone marrow-derived mesenchymal stem cells trigger a cascade of cellular events leading to the formation of an ectopic bone regenerative niche.

Authors:  Roberta Tasso; Valentina Ulivi; Daniele Reverberi; Claudia Lo Sicco; Fiorella Descalzi; Ranieri Cancedda
Journal:  Stem Cells Dev       Date:  2013-09-14       Impact factor: 3.272

3.  Hypoxic Conditioned Medium From Human Adipose-Derived Stem Cells Promotes Mouse Liver Regeneration Through JAK/STAT3 Signaling.

Authors:  Sang Chul Lee; Hye Jin Jeong; Sang Kuon Lee; Say-June Kim
Journal:  Stem Cells Transl Med       Date:  2016-04-21       Impact factor: 6.940

4.  Integrated mRNA and miRNA profiling revealed deregulation of cellular stress response in bone marrow mesenchymal stem cells derived from patients with immune thrombocytopenia.

Authors:  Jia-Min Zhang; Xiao-Lu Zhu; Jing Xue; Xiao Liu; X Long Zheng; Ying-Jun Chang; Kai-Yan Liu; Xiao-Jun Huang; Xiao-Hui Zhang
Journal:  Funct Integr Genomics       Date:  2018-02-13       Impact factor: 3.410

Review 5.  Inflammation and mesenchymal stem cell aging.

Authors:  Günter Lepperdinger
Journal:  Curr Opin Immunol       Date:  2011-06-22       Impact factor: 7.486

Review 6.  The emerging role of PEDF in stem cell biology.

Authors:  Mina Elahy; Swati Baindur-Hudson; Crispin R Dass
Journal:  J Biomed Biotechnol       Date:  2012-05-17

7.  Mesenchymal Stem Cells Derived from Healthy and Diseased Human Gingiva Support Osteogenesis on Electrospun Polycaprolactone Scaffolds.

Authors:  Catherine Jauregui; Suyog Yoganarasimha; Parthasarathy Madurantakam
Journal:  Bioengineering (Basel)       Date:  2018-01-23

8.  Interleukin-1 primes human mesenchymal stem cells towards an anti-inflammatory and pro-trophic phenotype in vitro.

Authors:  Elena Redondo-Castro; Catriona Cunningham; Jonjo Miller; Licia Martuscelli; Sarah Aoulad-Ali; Nancy J Rothwell; Cay M Kielty; Stuart M Allan; Emmanuel Pinteaux
Journal:  Stem Cell Res Ther       Date:  2017-04-17       Impact factor: 6.832

9.  The quality evaluation system establishment of mesenchymal stromal cells for cell-based therapy products.

Authors:  Yuanyuan Xie; Wei Liu; Shuo Liu; Liudi Wang; Dan Mu; Yi Cui; Yanyan Cui; Bin Wang
Journal:  Stem Cell Res Ther       Date:  2020-05-13       Impact factor: 6.832

Review 10.  Principal Criteria for Evaluating the Quality, Safety and Efficacy of hMSC-Based Products in Clinical Practice: Current Approaches and Challenges.

Authors:  Juan Antonio Guadix; Javier López-Beas; Beatriz Clares; José Luis Soriano-Ruiz; José Luis Zugaza; Patricia Gálvez-Martín
Journal:  Pharmaceutics       Date:  2019-10-24       Impact factor: 6.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.